EMA Authorised: Terrosa (teriparatide) — Gedeon Richter Plc.

View source ↗

Summary

The EU authorised Terrosa, a teriparatide product by Gedeon Richter, for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Terrosa (teriparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis. MAH: Gedeon Richter Plc.. Decision date: 23/04/2026